169 related articles for article (PubMed ID: 38519578)
1. Elevated postoperative carcinoembryonic antigen guides adjuvant chemotherapy for stage II colon cancer: a multicentre cohort retrospective study.
Pu H; Yang W; Liu M; Pang X; Chen Y; Xiong Q
Sci Rep; 2024 Mar; 14(1):6889. PubMed ID: 38519578
[TBL] [Abstract][Full Text] [Related]
2. Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.
Konishi T; Shimada Y; Hsu M; Tufts L; Jimenez-Rodriguez R; Cercek A; Yaeger R; Saltz L; Smith JJ; Nash GM; Guillem JG; Paty PB; Garcia-Aguilar J; Gonen M; Weiser MR
JAMA Oncol; 2018 Mar; 4(3):309-315. PubMed ID: 29270608
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
4. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
6. Dynamic monitoring of serum CEA and CA19-9 predicts the prognosis of postoperative stage II colon cancer.
Wang R; Xu B; Sun M; Pang X; Wang X; Zhu J; Lian J; Lu H
Eur J Surg Oncol; 2023 Dec; 49(12):107138. PubMed ID: 37925830
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer.
Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H
Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245
[TBL] [Abstract][Full Text] [Related]
8. The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study.
Liao L; Tang J; Hong Z; Jiang W; Li Y; Kong L; Han K; Hou Z; Zhang C; Zhou C; Zhang L; Sui Q; Xiao B; Mei W; Yu J; Yang W; Pan Z; Ding PR
BMC Cancer; 2024 Feb; 24(1):164. PubMed ID: 38302968
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy benefits on patients with elevated carcinoembryonic antigen in stage IIA colon cancer: a SEER-based analysis.
Zhou H; Wang S; Cai Z; Qiu E; Chen Q; Rao X; Han S; Li Z
Int J Colorectal Dis; 2022 Dec; 37(12):2481-2489. PubMed ID: 36334109
[TBL] [Abstract][Full Text] [Related]
10. Transient elevation in serum carcinoembryonic antigen while on adjuvant chemotherapy for colon cancer: Is this of prognostic importance?
Lawrence N; Hinder V; Murray M; Macapagal J; Thompson P; Sharples K; Findlay M
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e124-e131. PubMed ID: 26245738
[TBL] [Abstract][Full Text] [Related]
11. The robust performance of carcinoembryonic antigen levels after adjuvant chemotherapy for the recurrence risk stratification in patients with colorectal cancer.
Ozawa T; Matsuda K; Ishihara S; Fukushima Y; Shimada R; Hayama T; Nozawa K; Hashiguchi Y
J Surg Oncol; 2021 Jul; 124(1):97-105. PubMed ID: 33848373
[TBL] [Abstract][Full Text] [Related]
12. Survival Prediction and Adjuvant Chemotherapy Based on Tumor Marker for Stage IB Lung Adenocarcinoma.
Wang Y; Zheng D; Chen T; Zhang J; Yao F; Chen H
Ann Thorac Surg; 2020 Mar; 109(3):927-937. PubMed ID: 31614135
[TBL] [Abstract][Full Text] [Related]
13. Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer.
Ogata Y; Murakami H; Sasatomi T; Ishibashi N; Mori S; Ushijima M; Akagi Y; Shirouzu K
J Surg Oncol; 2009 Jan; 99(1):65-70. PubMed ID: 18942720
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
[TBL] [Abstract][Full Text] [Related]
15. High postoperative carcinoembryonic antigen as an indicator of high-risk stage II colon cancer.
Morimoto Y; Takahashi H; Arita A; Itakura H; Fujii M; Sekido Y; Hata T; Fujino S; Ogino T; Miyoshi N; Uemura M; Matsuda C; Yamamoto H; Mizushima T; Doki Y; Eguchi H
Oncol Lett; 2022 May; 23(5):167. PubMed ID: 35414828
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of CEA Improves Risk Stratification in Stage II Colon Cancer.
Spindler BA; Bergquist JR; Thiels CA; Habermann EB; Kelley SR; Larson DW; Mathis KL
J Gastrointest Surg; 2017 May; 21(5):770-777. PubMed ID: 28290141
[TBL] [Abstract][Full Text] [Related]
17. The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC).
Muley T; Rolny V; He Y; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Dienemann H; Meister M; Herth FJ; Dayyani F
Lung Cancer; 2018 Jun; 120():46-53. PubMed ID: 29748014
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
